Quantcast
Last updated on April 18, 2014 at 9:36 EDT

Latest radiation therapy Stories

2013-09-23 13:04:18

When treated with stereotactic radiosurgery (SRS), that is not combined with whole brain radiotherapy (WBRT), adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Younger patients (under 50 years old) were also found to be at no greater risk of new brain metastases developing despite omission of WBRT. A highly advanced...

2013-09-23 13:02:17

Due to decreased side effects, it may also be cost-saving Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study...

2013-09-23 12:42:42

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also indicated that the combined treatments produced acceptable levels of toxicity. The randomized, controlled trial studied a total of 147 women in Brazil with stage IIIB squamous cell...

2013-09-23 12:41:22

Patients receiving radiotherapy (RT) for cancers in the pelvic region can experience diarrhea, a negative side effect of radiation treatment. Sulfasalazine, an oral tablet used to treat inflammation of the bowels, had been shown in a past trial of 31 patients to decrease diarrhea during pelvic RT (Killic 2001). Sulfasalazine does not reduce diarrhea, according to research presented today at the American Society of Radiation Oncology's (ASTRO's) 55th Annual Meeting. The study also determined...

2013-09-23 12:40:17

When used to treat pediatric patients with intracranial malignant tumors, proton therapy may limit the toxicity of radiation therapy while preserving tumor control, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Typically, central nervous system malignancies are treated with surgical resection and post-operative radiation therapy. Proton therapy, an external beam radiation therapy in which protons deliver precise...

2013-09-23 11:37:22

Cancer patients can be accurately screened for major depression with a simple two-question survey, according to a study presented Sept. 23 at the American Society for Radiation Oncology's 55th Annual Meeting. The two-question screening test proved to be as accurate as a longer nine-question screening test. The study was presented at plenary session by William Small, Jr., MD, FASTRO, chair of the Department of Radiation Oncology of Loyola University Medical Center. "We found that a...

2013-09-23 08:29:40

Results of a multi-institutional randomized phase II trial (RTOG 0915/NCCTG N0927) presented at the 2013 annual meeting of the American Society for Radiation Oncology (ASTRO) ATLANTA, Sept. 23, 2013 /PRNewswire/ -- Treating inoperable early-stage non-small cell lung cancer (NSCLC) with a single session of stereotactic body radiation therapy (SBRT) may be a viable option in some cases, according to the results of a multi-institutional randomized phase II trial led by the Radiation...

2013-09-23 08:29:34

-- Innovative solutions transform the way care is delivered and improve care for oncology patients who require radiation treatment ATLANTA, Sept. 23, 2013 /PRNewswire/ -- At the 55(th) American Society for Radiation Oncology (ASTRO) annual meeting, September 22-25 in Atlanta, Royal Philips (NYSE: PHG, AEX: PHIA) will feature the latest innovations that address efficient and personalized radiation oncology care for patients and their clinicians. The Philips solutions featured at ASTRO 2013...

2013-09-23 08:29:09

Learning and Innovation Center (LINC) to draw thousands to Atlanta ATLANTA, Sept. 23, 2013 /PRNewswire/ - Elekta will unveil a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Atlanta. (Photo: http://photos.prnewswire.com/prnh/20130923/CL82461) The Learning and Innovation Center (LINC) is expected to draw clinicians, researchers and health IT...

2013-09-23 08:28:39

New RapidPlan(TM) software is designed to expedite creation of complex IMRT treatment plans, improving quality, consistency, and efficiency ATLANTA, Sept. 23, 2013 /PRNewswire/ -- ASTRO Booth #1115 -- Varian Medical Systems (NYSE: VAR) is showcasing a new knowledge-based software tool designed to expedite creation of complex intensity-modulated radiotherapy (IMRT) treatment plans at the 54(th) annual meeting of the American Society for Radiation Oncology (ASTRO) this week....